En Carta Diagnostics raised €5.0M in a funding round in Jul 2026. The company is based in Paris, France. Investors in the round: 50 Partners Health, Blue Forest Ventures, Bpifrance and 3 others. Data as of 10 Jul 2026.
Reported in EUR — no conversion. €5.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
